Page last updated: 2024-08-24

opc 14117 and thyrotropin-releasing hormone

opc 14117 has been researched along with thyrotropin-releasing hormone in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirose, T; Kikuchi, T; Oshiro, Y; Sakurai, Y; Tanaka, T; Tottori, K1
Kikuchi, T; Kurahashi, N; Miwa, T; Nishi, T; Oshiro, Y; Sakurai, Y; Sato, S; Tanaka, T; Tottori, K; Uwahodo, Y1

Other Studies

2 other study(ies) available for opc 14117 and thyrotropin-releasing hormone

ArticleYear
Novel cerebroprotective agents with central nervous system stimulating activity. 2. Synthesis and pharmacology of the 1-(acylamino)-7-hydroxyindan derivatives.
    Journal of medicinal chemistry, 1991, Volume: 34, Issue:7

    Topics: Animals; Central Nervous System Stimulants; Chemical Phenomena; Chemistry; Coma; Hypoxia; Indans; Lipid Peroxidation; Male; Mice; Mice, Inbred ICR; Rats; Rats, Inbred Strains; Structure-Activity Relationship

1991
3,4-dihydro-2(1H)-quinolinone as a novel antidepressant drug: synthesis and pharmacology of 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-3,4- dihydro-5-methoxy-2(1H)-quinolinone and its derivatives.
    Journal of medicinal chemistry, 2000, Jan-27, Volume: 43, Issue:2

    Topics: Animals; Antidepressive Agents; Brain Concussion; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred ICR; Piperazines; Quinolones; Rats; Rats, Wistar; Receptors, sigma; Structure-Activity Relationship

2000